AI Startup Intelligence
Healthcare AI Startups
Explore healthcare AI startups across clinical workflow, diagnostics, drug discovery, patient operations, and provider productivity.
Companies tracked: 506Key segments: clinical workflow, diagnostics, drug discoveryUpdated: September 27, 2026
Healthcare AI Market Snapshot
506
tracked companies
8
visible location clusters
8
funding signals surfaced
Healthcare AI is splitting between regulated clinical use cases and operational automation that can show faster budget ownership.
Representative Companies
A crawler-visible sample of companies from the AI Market Watch database.
| Company | Location | Funding | Focus |
|---|---|---|---|
| Pharus Diagnostics Founded 2022 | Los Angeles, California, USA. Originally spun out from Hsinchu, Taiwan-based Quark Biosciences. | Not publicly disclosed | AI-powered liquid biopsy tests for early cancer detection and comprehensive patient journey management using microRNA (miRNA) biomarkers. |
| Triomics Founded 2021 | New York, NY | $38.6M | Oncology-specific AI platform that automates clinical trial matching, visit preparation, and cancer registry abstraction for cancer centers. |
| Autonomize AI Founded 2022 | Austin, TX, USA | $32 million | An AI-powered copilot platform that organizes, contextualizes, and summarizes unstructured data to reduce administrative burden and improve decision-making for healthcare and life sciences organizations. |
| Elion Founded 2022 | New York, United States | $12.6 million | An AI-powered research and intelligence platform for healthcare technology, acting as a marketplace for health IT decision-makers. |
| Ovum Founded 2023 | Sydney, Australia | $5.7 million | An AI-powered intelligent health journal and mobile app designed to empower women to track symptoms, gain personalized health insights, and advocate for better healthcare outcomes. |
| Ark Founded 2018 | Busan, South Korea | $15.0M | AI-powered retinal diagnosis platform that analyzes fundus camera images in 3-5 seconds to detect 3 major blinding diseases (age-related macular degeneration, glaucoma, diabetic retinopathy) and predict risks for cardiovascular and chronic kidney diseases. |
| Healthee Founded 2021 | 213 West 35th Street, New York, NY (with a presence in Israel) | $104 million | An AI-powered platform that simplifies employee health benefits navigation by providing instant personalized answers, cost transparency, provider search, appointment booking, and preventive care recommendations. |
| Salt AI Founded 2023 | Los Angeles, USA | $13M | A contextual AI platform and collaborative operating system for life sciences that connects specialized models and datasets into interpretable, auditable AI workflows |
| NEX Health Intelligence Founded 2022 | London, United Kingdom | $1.5M | AI-powered infection intelligence platform that helps hospitals detect, predict and prevent healthcare-associated infections before they spread. |
| Abridge Founded 2018 | Pittsburgh, Pennsylvania, USA | $757.5M | An AI-powered platform that records and transforms patient-clinician conversations into structured, summarized clinical notes directly within the electronic health record (EHR). |
| Jimini Health Founded 2023 | New York, United States | $25.0M | An AI-powered behavioral health platform that augments traditional therapy with continuous AI support between sessions through Sage, a clinically supervised AI assistant that works as part of the care team. |
| Nimblemind.ai Founded 2024 | Chicago, USA | $2.5 million | AI-powered data infrastructure platform that helps healthcare providers structure and leverage clinical data. |
| Sychedelic Founded 2024 | Gurugram, Delhi NCR, India (also New York, US entity) | $3.5M | Sychedelic builds AI-powered neurostimulation headphones that combine PPG sensors, adaptive audio, and tDCS to reduce stress, improve focus, and enhance sleep through real-time closed-loop neuromodulation. |
| Limpid Founded 2020 | Daegu, South Korea | $6.43M | A data-driven pet healthcare platform that utilizes veterinary expertise and multimodal AI to provide medical-grade precision nutrition and health management solutions. |
| Rakovina Therapeutics (with NanoPalm JV collaboration) Founded 2020 | North America and the Middle East (Canada and Riyadh, Saudi Arabia) | Rakovina Therapeutics has raised at least $7.5M (including a $1.99M non-brokered private placement closed August 2026), and NanoPalm has raised $5M. | A joint venture developing an AI-driven oncology pipeline with a scalable lipid nanoparticle (LNP) delivery system. |
| BloodGPT Founded 2024 | Nicosia, Cyprus | $1 million | An AI-powered platform that analyzes and interprets complex blood test reports, delivering actionable insights in under two minutes. |
| Blossom Health Founded 2024 | New York City, USA | $20.0M | An AI-native operating system for psychiatry that automates administrative workflows and provides clinical copilots to transform episodic mental healthcare into a continuous, data-driven relationship. |
| Apella Founded 2019 | San Francisco, USA | $104.3M | An ambient AI and computer vision platform designed to digitize the operating room, automating surgical documentation and providing real-time operational intelligence to improve hospital efficiency. |
| Qure Founded 2016 | Mumbai, India | $123.0M | A global health-tech platform utilizing deep learning to provide automated interpretation of medical images including X-rays, CT scans, and ultrasounds. |
| eMed Founded 2020 | Miami, USA | $200.0M | A digital healthcare platform pioneering the 'Test-to-Treat' model by combining at-home diagnostic testing with live-proctored verification and immediate AI-driven telehealth services. |
Funding Signals
Pharus Diagnostics
Series A, $11.0M, 2022-07, led by CK Hutchison Holdings
Investors: CK Hutchison Holdings, CK Life Sciences International, LCY Group, Lee Family Office, Larta Institute, Quark Biosciences
Triomics
Series B
Investors: ["Battery Ventures","Lightspeed","Nexus Venture Partners","General Catalyst","Y Combinator","Progression.Fund","Oncology Ventures","Precision Health Informatics"]
Autonomize AI
Series A ($28 million)
Investors: Valtruis, The Cigna Group Ventures, Tau Ventures, Asset Management Ventures, ATX Venture Partners, Loop Ventures
Elion
Seed
Investors: ["NEA","Cedars Sinai Health Ventures","TMV","Scrub Capital","Alumni Ventures"]
Ovum
Seed, $1.7M, 2025-02, led by Giant Leap
Investors: ["Giant Leap","Antler","Alice Anderson Fund","Wollemi Capital Group","Admiralty Capital Group","Foggy Valley Aotearoa","Aviron Investments","Brisbane Angels","Think & Grow"]
Ark
Series A
Investors: ["DSC Investment","Kiwoom Investment","Aju IB Investment","SL Investment","Platinum Technology Investment","Wooshin Ventures"]
Healthee
$50 Million Series B (April 2025)
Investors: Group 11, Fin Capital, Glilot Capital Partners, Key1 Capital
Salt AI
Seed
Investors: ["Morpheus Ventures","Struck Capital","Marbruck Investments","CoreWeave","Irregular Expressions"]